<?xml version="1.0"?>
<Articles JournalTitle="Iranian Journal of Allergy, Asthma and Immunology">
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Iranian Journal of Allergy, Asthma and Immunology</JournalTitle>
      <Issn>1735-1502</Issn>
      <Volume>12</Volume>
      <Issue>2</Issue>
      <PubDate PubStatus="epublish">
        <Year>2013</Year>
        <Month>06</Month>
        <Day>15</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Differential Allergenicity of Mature and Immature Pollen Grains in Shasta Daisy (Chrysanthemum maximum Ramond)</title>
    <FirstPage>99</FirstPage>
    <LastPage>106</LastPage>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Maryam</FirstName>
        <LastName>Sharif Shoushtari</LastName>
        <affiliation locale="en_US">Immunology, Asthma and Allergy Research Institute, Tehran University of Medical Sciences, Tehran, Iran AND Department of Biology, Faculty of Biology Science, Islamic Azad University, North Tehran Branch, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Ahmad</FirstName>
        <LastName>Majd</LastName>
        <affiliation locale="en_US">Department of Biology, Faculty of Biology Science, Islamic Azad University, North Tehran Branch, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Zahra</FirstName>
        <LastName>Pourpak</LastName>
        <affiliation locale="en_US">Immunology, Asthma and Allergy Research Institute, Tehran University of Medical Sciences, Tehran, Iran AND Department of Immunology and Allergy, Children Medical Center, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Youcef</FirstName>
        <LastName>Shahali</LastName>
        <affiliation locale="en_US">Laboratoire &#x201C;Sciences Analytiques, Bioanalytiques et Miniaturisation&#x201D;, ESPCI ParisTech, UMR 7195 CNRS, 75231 Paris cedex 05, France</affiliation>
      </Author>
      <Author>
        <FirstName>Mostafa</FirstName>
        <LastName>Moin</LastName>
        <affiliation locale="en_US">Immunology, Asthma and Allergy Research Institute, Tehran University of Medical Sciences, Tehran, Iran AND Department of Immunology and Allergy, Children Medical Center, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Mohammad Bagger</FirstName>
        <LastName>Eslami</LastName>
        <affiliation locale="en_US">Department of Pathobiology, Immunology Division, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2015</Year>
        <Month>10</Month>
        <Day>16</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Weed pollen grains belonging to&#xA0; the&#xA0; Asteraceae&#xA0; family contain&#xA0; a variety of&#xA0; allergens inducing type I&#xA0; and IV allergies in susceptible people. The&#xA0; aim of this research was to compare&#xA0; the&#xA0; allergenic properties&#xA0; of&#xA0; immature&#xA0; and&#xA0; mature&#xA0; Shasta&#xA0; daisy pollen&#xA0; grains (Chrysanthemum maximum Ramond) to define the potential role of the maturation process on the allergenicity of Asteraceae pollen grains.
The&#xA0; immature (IP) and mature&#xA0; pollen (MP) grains were first studied by optical and scanning electron microscopand their protein contents were quantitatively and qualitatively analyzed. Pollen extracts were finally used to sensitize guinea pigs in order to obtain IP and MP specific antibodies. Nasal provocation tests using IP and MP crude extracts were also performed on pre-sensitized guinea pigs.
The&#xA0; MP&#xA0; extract&#xA0; induced&#xA0; IgE&#xA0; and&#xA0; eosinophilia in&#xA0; blood&#xA0; and&#xA0; positive skin&#xA0; tests&#xA0; in sensitized guinea pigs. Moreover, high number of eosinophils was found in the nasal mucosa of MP sensitized guinea pigs. SDS-PAGE analysis of the IP and MP protein content showed seven and five apparent bands ranging from 7 to 66kDa respectively.
According to immunoblot analysis, MP extract contained a single allergen of 66kDa. The overall results showed developmental processes of Shasta daisy pollen grains towards both morphological and molecular changes increasing their allergenic potency.</abstract>
    <web_url>https://ijaai.tums.ac.ir/index.php/ijaai/article/view/526</web_url>
    <pdf_url>https://ijaai.tums.ac.ir/index.php/ijaai/article/download/526/479</pdf_url>
  </Article>
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Iranian Journal of Allergy, Asthma and Immunology</JournalTitle>
      <Issn>1735-1502</Issn>
      <Volume>12</Volume>
      <Issue>2</Issue>
      <PubDate PubStatus="epublish">
        <Year>2013</Year>
        <Month>06</Month>
        <Day>15</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Raised Interleukin-13 Levels in Cord Blood Increases the Risk of Allergic Sensitization at 5 Years of Age</title>
    <FirstPage>107</FirstPage>
    <LastPage>114</LastPage>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Nevin</FirstName>
        <LastName>Uzuner</LastName>
        <affiliation locale="en_US">Dokuz Eylul University Hospital, Department of Pediatric Allergy, 35340, Balcova, Izmir, Turkey.</affiliation>
      </Author>
      <Author>
        <FirstName>Arzu</FirstName>
        <LastName>Babayigit Hocaoglu</LastName>
        <affiliation locale="en_US">Dokuz Eylul University Hospital, Department of Pediatric Allergy, 35340, Balcova, Izmir, Turkey.</affiliation>
      </Author>
      <Author>
        <FirstName>Duygu</FirstName>
        <LastName>Olmez Erge</LastName>
        <affiliation locale="en_US">Dokuz Eylul University Hospital, Department of Pediatric Allergy, 35340, Balcova, Izmir, Turkey.</affiliation>
      </Author>
      <Author>
        <FirstName>Suna</FirstName>
        <LastName>Asilsoy</LastName>
        <affiliation locale="en_US">Baskent University Hospital, Department of Pediatric Allergy, Adana, Turkey</affiliation>
      </Author>
      <Author>
        <FirstName>Ozkan</FirstName>
        <LastName>Karaman</LastName>
        <affiliation locale="en_US">Dokuz Eylul University Hospital, Department of Pediatric Allergy, 35340, Balcova, Izmir, Turkey.</affiliation>
      </Author>
      <Author>
        <FirstName>Zekiye</FirstName>
        <LastName>Altun</LastName>
        <affiliation locale="en_US">Dokuz Eylul University Hospital, Department of Biochemistry, 35340, Balcova, Izmir, Turkey</affiliation>
      </Author>
      <Author>
        <FirstName>Abdullah</FirstName>
        <LastName>Kumral</LastName>
        <affiliation locale="en_US">Dokuz Eylul University Hospital, Department of Neonatology, 35340, Balcova, Izmir, Turkey</affiliation>
      </Author>
      <Author>
        <FirstName>Ozlem</FirstName>
        <LastName>Tufekci</LastName>
        <affiliation locale="en_US">Dokuz Eylul University Hospital, Department of Pediatric Allergy, 35340, Balcova, Izmir, Turkey.</affiliation>
      </Author>
      <Author>
        <FirstName>Huray</FirstName>
        <LastName>Islekel</LastName>
        <affiliation locale="en_US">Dokuz Eylul University Hospital, Department of Biochemistry, 35340, Balcova, Izmir, Turkey</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2015</Year>
        <Month>10</Month>
        <Day>16</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">The identification of early markers of atopy in cord blood of newborns at delivery may offer prediction of future allergic sensitization. The aim of this study was to evaluate the relationship between cord blood interleukin-13 (IL-13) and interferon-gamma (IFN-&#x3B3;) and development of allergic diseases during the first five years of life. Umbilical cord blood samples were collected at the time of delivery from 62 newborns. The families of these newborns were asked to complete a questionnaire about age and education of parents, number of siblings, allergic diseases in family members, cigarette exposure during pregnancy and presence of pets in their house. The same subjects were evaluated when they were five years old. Venous blood samples were drawn and epidermal skin prick tests were performed. IL-13 and interferon-gamma (IFN-&#x3B3;) levels were studied from the blood samples which were taken during birth and five years later. There was no significant relationship between gender, type of delivery, educational levels of parents, exposure to cigarette smoke, atopy in parents, presence of pets in the house and IL-13 and IFN-&#x3B3; levels in cord blood and at five years. Higher levels of IL-13 in newborns and five years olds, were found significantly related to skin prick test positivity (p=0.004 and p&lt;0.0001, respectively) and presence of allergic diseases (p= 0.008 and p= 0.001, respectively). Levels of IFN-&#x3B3;, both in cord blood and five years after, were not related with the future of allergic status of children. Higher levels of IL-13 in cord blood may be a predictor of future development of allergic sensitization.</abstract>
    <web_url>https://ijaai.tums.ac.ir/index.php/ijaai/article/view/525</web_url>
    <pdf_url>https://ijaai.tums.ac.ir/index.php/ijaai/article/download/525/483</pdf_url>
  </Article>
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Iranian Journal of Allergy, Asthma and Immunology</JournalTitle>
      <Issn>1735-1502</Issn>
      <Volume>12</Volume>
      <Issue>2</Issue>
      <PubDate PubStatus="epublish">
        <Year>2013</Year>
        <Month>06</Month>
        <Day>15</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Is Acetaminophen Use Associated with Atopic Eczema and other Allergic Diseases in Adolescents?</title>
    <FirstPage>115</FirstPage>
    <LastPage>123</LastPage>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Mar&#xED;a Morales</FirstName>
        <LastName>Su&#xE1;rez-Varela</LastName>
        <affiliation locale="en_US">Public and Environmental Health Unit, Department of Preventive Medicine, University of Valencia, CIBER Epidemiology and Public Health (CIBERESP), and Center for Public Health Research (CSISP), Valencia, Spain</affiliation>
      </Author>
      <Author>
        <FirstName>Lu&#xED;s</FirstName>
        <LastName>Garc&#xED;a-Marcos</LastName>
        <affiliation locale="en_US">Pediatric Respiratory and Allergy Units, &#x201C;Arrixaca&#x201D; University Children&#x2019;s Hospital, University of Murcia, and CIBER of Epidemiology and Public Health (CIBERSP), Murcia, Spain</affiliation>
      </Author>
      <Author>
        <FirstName>Javier Fuertes</FirstName>
        <LastName>Fern&#xE1;ndez-Espinar</LastName>
        <affiliation locale="en_US">Perpetuo Socorro&#x201D; Health Center, Huesca, Spain</affiliation>
      </Author>
      <Author>
        <FirstName>Alberto</FirstName>
        <LastName>Bercedo-Sanz</LastName>
        <affiliation locale="en_US">Meruelo&#x201D; Health Center, Santander, Spain</affiliation>
      </Author>
      <Author>
        <FirstName>In&#xE9;s</FirstName>
        <LastName>Aguinaga-Ontoso</LastName>
        <affiliation locale="en_US">Department of Health Sciences, Public University of Navarra, Pamplona, Spain</affiliation>
      </Author>
      <Author>
        <FirstName>Carlos</FirstName>
        <LastName>Gonz&#xE1;lez-D&#xED;az</LastName>
        <affiliation locale="en_US">Department of Pediatrics, Basurto Hospital, Bilbao, Spain</affiliation>
      </Author>
      <Author>
        <FirstName>Ignacio</FirstName>
        <LastName>Carvajal-Urue&#xF1;a</LastName>
        <affiliation locale="en_US">La Er&#xED;a&#x201D; Health Center, Oviedo, Asturias Princedom Health Service, Asturias, Spain</affiliation>
      </Author>
      <Author>
        <FirstName>Rosa Mar&#xED;a</FirstName>
        <LastName>Busquet-Monge</LastName>
        <affiliation locale="en_US">Department of Pediatrics, Hospital del Mar, Barcelona, Spain</affiliation>
      </Author>
      <Author>
        <FirstName>Alberto</FirstName>
        <LastName>Arnedo-Pena</LastName>
        <affiliation locale="en_US">Centre of Public Health, Regional Health Authority, Castell&#xF3;n, Spain</affiliation>
      </Author>
      <Author>
        <FirstName>Nagore</FirstName>
        <LastName>Garc&#xED;a de Andoin</LastName>
        <affiliation locale="en_US">Department of Pediatrics, &#x201C;Donostia&#x201D; Hospital, San Sebasti&#xE1;n, Guipuzcoa, Spain</affiliation>
      </Author>
      <Author>
        <FirstName>Jos&#xE9;</FirstName>
        <LastName>Batlles-Garrido</LastName>
        <affiliation locale="en_US">Department of Pediatrics, &#x201C;Torrec&#xE1;rdenas&#x201D; Hospital, Almer&#xED;a, Spain</affiliation>
      </Author>
      <Author>
        <FirstName>Alfredo</FirstName>
        <LastName>Blanco-Quir&#xF3;s</LastName>
        <affiliation locale="en_US">Department of Pediatrics, University of Valladolid, Spain</affiliation>
      </Author>
      <Author>
        <FirstName>Angel</FirstName>
        <LastName>L&#xF3;pez-Silvarrey Varela</LastName>
        <affiliation locale="en_US">Mar&#xED;a Jos&#xE9; Jove Foundation, La Coru&#xF1;a, Spain</affiliation>
      </Author>
      <Author>
        <FirstName>Gloria</FirstName>
        <LastName>Garc&#xED;a-Hern&#xE1;ndez</LastName>
        <affiliation locale="en_US">Pediatric Allergy and Pulmonology Unit. &#x201C;12 de Octubre&#x201D; University Children&#x2019;s Hospital, Madrid, Spain</affiliation>
      </Author>
      <Author>
        <FirstName>Natalia</FirstName>
        <LastName>Gimeno-Clemente</LastName>
        <affiliation locale="en_US">Public and Environmental Health Unit, Department of Preventive Medicine, University of Valencia, CIBER Epidemiology and Public Health (CIBERESP), and Center for Public Health Research (CSISP), Valencia, Spain</affiliation>
      </Author>
      <Author>
        <FirstName>Nuria</FirstName>
        <LastName>Rubio-L&#xF3;pez</LastName>
        <affiliation locale="en_US">Public and Environmental Health Unit, Department of Preventive Medicine, University of Valencia, CIBER Epidemiology and Public Health (CIBERESP), and Center for Public Health Research (CSISP), Valencia, Spain</affiliation>
      </Author>
      <Author>
        <FirstName>Agust&#xED;n</FirstName>
        <LastName>Llopis-Gonz&#xE1;lez</LastName>
        <affiliation locale="en_US">Public and Environmental Health Unit, Department of Preventive Medicine, University of Valencia, CIBER Epidemiology and Public Health (CIBERESP), and Center for Public Health Research (CSISP), Valencia, Spain</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2015</Year>
        <Month>10</Month>
        <Day>16</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Atopic Eczema (AE) is a chronic inflammatory skin disease that affects children and adults, and&#xA0; alters&#xA0; quality&#xA0; of&#xA0; life.&#xA0; Previous&#xA0; studies&#xA0; have suggested several&#xA0; socio-demographic&#xA0;&#xA0; and environmental factors related to the prevalence of AE and other allergic diseases,&#xA0; including acetaminophen use. In the present study, we report the rates of isolated AE, AE associated with asthma and AE associated with rhinitis among 13- to 14-year-old Spanish adolescents and the level of association of these conditions with the use of acetaminophen. We analyzed Spanish data from a cross-sectional Phase 3 study within ISAAC. A total of 28,717 adolescents completed the Phase 3 written questionnaire by answering questions for acetaminophen use and on asthma, rhinitis and AE symptoms.
We observed an association between acetaminophen use and AE among the adolescents who had used acetaminophen in the previous month. Furthermore, the prevalence rate increased with the number of allergic processes: for AE alone, the adjusted Prevalence Ratio (aPR) was 1.81 and for AE associated with rhinitis or with asthma, aPRs were 2.20 and 3.03, respectively.
We conclude that acetaminophen use in childhood&#xA0; may be an important factor associated with development and/or maintenance of AE and other allergic diseases.</abstract>
    <web_url>https://ijaai.tums.ac.ir/index.php/ijaai/article/view/524</web_url>
    <pdf_url>https://ijaai.tums.ac.ir/index.php/ijaai/article/download/524/486</pdf_url>
  </Article>
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Iranian Journal of Allergy, Asthma and Immunology</JournalTitle>
      <Issn>1735-1502</Issn>
      <Volume>12</Volume>
      <Issue>2</Issue>
      <PubDate PubStatus="epublish">
        <Year>2013</Year>
        <Month>06</Month>
        <Day>15</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Remission of Childhood Asthma after Entering the Second Decade of Life: A Hospital Based Cohort</title>
    <FirstPage>124</FirstPage>
    <LastPage>128</LastPage>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Shideh</FirstName>
        <LastName>Assar</LastName>
        <affiliation locale="en_US">Department of Pediatrics, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Esmaeil</FirstName>
        <LastName>Idani</LastName>
        <affiliation locale="en_US">Departments of Respiratory Disease and Internal Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Mehdi</FirstName>
        <LastName>Monajemzadeh</LastName>
        <affiliation locale="en_US">Department of Pediatrics, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Masoome</FirstName>
        <LastName>Ganai</LastName>
        <affiliation locale="en_US">Department of Pediatrics, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Fakher</FirstName>
        <LastName>Rahim</LastName>
        <affiliation locale="en_US">Cellular and Molecular Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2015</Year>
        <Month>10</Month>
        <Day>16</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Asthma is the most common chronic disease in children. The natural history of asthma is often&#xA0; characterized by periods&#xA0; of&#xA0; remission and&#xA0; relapse. The&#xA0; aim of&#xA0; this study was to determine the remission rate of asthmatic children after entering the second decade of life and remission related factors in a hospital&#x2013;based cohort.
The&#xA0; study&#xA0; population&#xA0; was&#xA0; asthmatic&#xA0; children&#xA0; who&#xA0; were&#xA0; diagnosed,&#xA0; registered&#xA0; and followed up in outpatient pediatric clinic of a university hospital in Ahvaz, Iran. Remission was assessed in the age of 11 to 15 years-old if &#x2265; 5 years passed from the time of diagnosis. Clinical remission was defined as the absence of asthma symptoms for at least one year without the use of inhaled corticosteroids and short acting &#x3B2;2 agonists.
In the cases with clinical remission, spirometry and exercise tests were conducted&#xA0; to document complete remission. The study included 197 adolescents (mean age of 13.1&#xB1;1.9 years). Clinical remissions were found in 71 cases (%36) but according to spirometry criteria,65 children (33%) were in complete remission. There was no significant difference between the genders. The remission rate was positively correlated with age of onset, and inversely correlated with family history of asthma, atopic dermatitis, hospitalization due to asthma, passive smoking and the need to use long-term inhaled corticosteroid.
Based on this study, approximately one third of asthmatic children showed remission up to 15 years of age which is a moderate rate compared to other studies.</abstract>
    <web_url>https://ijaai.tums.ac.ir/index.php/ijaai/article/view/523</web_url>
    <pdf_url>https://ijaai.tums.ac.ir/index.php/ijaai/article/download/523/492</pdf_url>
  </Article>
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Iranian Journal of Allergy, Asthma and Immunology</JournalTitle>
      <Issn>1735-1502</Issn>
      <Volume>12</Volume>
      <Issue>2</Issue>
      <PubDate PubStatus="epublish">
        <Year>2013</Year>
        <Month>06</Month>
        <Day>15</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">No Direct Association among Respiratory Function, Disease Control and Family Functioning in a Sample of Mexican Children with Intermittent Asthma</title>
    <FirstPage>129</FirstPage>
    <LastPage>135</LastPage>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Alain Raimundo</FirstName>
        <LastName>Rodriguez-Orozco</LastName>
        <affiliation locale="en_US">Facultad de Ciencias M&#xE9;dicas y Biol&#xF3;gicas &#x201C;Dr Ignacio Ch&#xE1;vez&#x201D;. Universidad Michoacana de San Nicol&#xE1;s De Hidalgo. Instituto de Investigaci&#xF3;n Cient&#xED;fica en temas de Familia, Alergia e Inmunolog&#xED;a, Morelia, M&#xE9;xico</affiliation>
      </Author>
      <Author>
        <FirstName>Rosa Mar&#xED;a</FirstName>
        <LastName>N&#xFA;&#xF1;ez-Tapia</LastName>
        <affiliation locale="en_US">Unidad de Medicina Familiar No 80 del Instituto Mexicano del Seguro Social, Morelia, M&#xE9;xico</affiliation>
      </Author>
      <Author>
        <FirstName>Armando</FirstName>
        <LastName>Ram&#xED;rez-Silva</LastName>
        <affiliation locale="en_US">Unidad de Medicina Familiar No 80 del Instituto Mexicano del Seguro Social, Morelia, M&#xE9;xico</affiliation>
      </Author>
      <Author>
        <FirstName>Carlos</FirstName>
        <LastName>G&#xF3;mez-Alonso</LastName>
        <affiliation locale="en_US">Centro de Investigaciones Biom&#xE9;dicas de Occidente. Instituto Mexicano del Seguro Social, Morelia, M&#xE9;xico</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2015</Year>
        <Month>10</Month>
        <Day>16</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Asthma has been linked to family disfunctioning and poor control of the disease.
This study was conducted to analyze the interactions between the level of intermittent asthma control, family functioning and respiratory function and between quality of life of asthmatic patients and their caregivers.
7 to 15 years old children with intermittent asthma were included. Asthma Control Test Questionnaire,&#xA0; Pediatric&#xA0; Asthma&#xA0; Quality&#xA0; of&#xA0; Life&#xA0; Questionnaire&#xA0;&#xA0; (PAQLQ)&#xA0;&#xA0; test,&#xA0; and flowmetry were applied&#xA0; to&#xA0; children&#xA0; and&#xA0; Pediatric&#xA0; Asthma&#xA0; Caregiver&#xB4;s Quatily of&#xA0; Life Questionnaire&#xA0; (PAQCLQ) &#xA0;and&#xA0; the&#xA0; Family Functioning&#xA0; Perception&#xA0; Test&#xA0; (FF-SIL) were applied to their parents.
The most affected areas of family functioning in dysfunctional families were adaptability and permeability. A medium&#xA0; to&#xA0; high strength&#xA0; of&#xA0; association was founded&#xA0; between&#xA0; the emotional function of parents and the emotional function of children, R2=0.552. The most remarkable associations were among parents&#x2019; limitation of activities and parents' emotional function (r=0.837), parents&#x2019; limitation of activities and child's emotional function (r=0.722), parents' emotional role and limitation of activities (r=0.837), parents&#x2019; emotional role and emotional functioning of children with asthma (r=0.743) and the limitation of activities of children with asthma and the emotional function of children with asthma (r=0.870).
No&#xA0; direct associations were founded&#xA0; among respiratory function, disease control&#xA0; and family functioning in Mexican children with intermittent asthma and emotional function of parents and children were associated in both groups.</abstract>
    <web_url>https://ijaai.tums.ac.ir/index.php/ijaai/article/view/522</web_url>
    <pdf_url>https://ijaai.tums.ac.ir/index.php/ijaai/article/download/522/495</pdf_url>
  </Article>
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Iranian Journal of Allergy, Asthma and Immunology</JournalTitle>
      <Issn>1735-1502</Issn>
      <Volume>12</Volume>
      <Issue>2</Issue>
      <PubDate PubStatus="epublish">
        <Year>2013</Year>
        <Month>06</Month>
        <Day>15</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">The Main Relaxant Constituents of Nigella Sativa Methanolic Fraction on Guinea Pig Tracheal Chains</title>
    <FirstPage>136</FirstPage>
    <LastPage>143</LastPage>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Rana</FirstName>
        <LastName>Keyhanmanesh</LastName>
        <affiliation locale="en_US">Tuberculosis and Lung Research Center, Tabriz University of Medical Sciences, Tabriz, Iran AND Department of Physiology, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Horeyeh</FirstName>
        <LastName>Bagban</LastName>
        <affiliation locale="en_US">Department of Physiology, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Hossein</FirstName>
        <LastName>Nazemieh</LastName>
        <affiliation locale="en_US">Research Center for Pharmaceutical Nanotechnology, Faculty of Pharmacy, Tabriz University of Medical Sciences, Tabriz, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Fariba</FirstName>
        <LastName>Mirzaei Bavil</LastName>
        <affiliation locale="en_US">Department of Physiology, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Mohammad Reza</FirstName>
        <LastName>Alipour</LastName>
        <affiliation locale="en_US">Drug Applied Research Center, Tabriz University of Medical Sciences, Tabriz, Iran</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2015</Year>
        <Month>10</Month>
        <Day>16</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Our&#xA0; previous&#xA0; studies demonstrated&#xA0; the&#xA0; preventive effect&#xA0; of&#xA0; Nigella&#xA0; sativa&#xA0; extract&#xA0; on asthma and water-soluble substances of this extract, especially its methanol fraction were responsible for this relaxation on contracted tracheal chains of guinea pigs. For the first time, the present study has been conducted to determine the main constituents of its methanolic extract.
Four constituents of 20%-methanolic fraction, consisting of two flavonoids (20-20% and 21-20% fractions) and two polysaccharides (1-20% and 2-20% fractions), were purified by analytical and&#xA0; preparative&#xA0; HPLC.&#xA0; The&#xA0; relaxant&#xA0; effects&#xA0; of&#xA0; four&#xA0; cumulative&#xA0; concentrations&#xA0; of&#xA0; each constituent (50, 100, 150 and 200 mg/lit) in comparison with saline (1 ml) as negative control and four cumulative concentrations of theophylline (0.2, 0.4, 0.6 and 0.8 mM) as positive control were examined on methacholine-precontracted guinea pig tracheal chains (n=6).
All concentrations&#xA0; of theophylline and most concentrations&#xA0; of 20-20, 21-20 fractions showed significant relaxant effects compared to&#xA0; that&#xA0; of saline. 20-20 fraction (Comferol diglucoside) was the most potent bronchodilator. Their relaxant effects were lower than that of theophylline. Polysaccharides (1-20, 2-20 fractions) did not&#xA0; have any relaxant effects compared to that of saline.
These results revealed that two flavonoids of 20%-methanolic fraction of Nigella&#xA0; sativa were its main relaxant constituents.</abstract>
    <web_url>https://ijaai.tums.ac.ir/index.php/ijaai/article/view/521</web_url>
    <pdf_url>https://ijaai.tums.ac.ir/index.php/ijaai/article/download/521/497</pdf_url>
  </Article>
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Iranian Journal of Allergy, Asthma and Immunology</JournalTitle>
      <Issn>1735-1502</Issn>
      <Volume>12</Volume>
      <Issue>2</Issue>
      <PubDate PubStatus="epublish">
        <Year>2013</Year>
        <Month>06</Month>
        <Day>15</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Increased Expression of Transforming Growth Factor-&#x3B2; and Receptors in Primary Human Airway Fibroblasts from Chemical Inhalation Patients</title>
    <FirstPage>144</FirstPage>
    <LastPage>152</LastPage>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Monireh Sadat</FirstName>
        <LastName>Mirzamani</LastName>
        <affiliation locale="en_US">Genomics Division, Systems Biology Institute, Chemical Injury Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran AND Department of Biology, Faculty of Sciences, Urmia University, Urmia, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Mohammad Reza</FirstName>
        <LastName>Nourani</LastName>
        <affiliation locale="en_US">Genomics Division, Systems Biology Institute, Chemical Injury Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Abbas Ali</FirstName>
        <LastName>Imani Fooladi</LastName>
        <affiliation locale="en_US">Applied Microbiology Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Samad</FirstName>
        <LastName>Zare</LastName>
        <affiliation locale="en_US">Department of Biology, Faculty of Sciences, Urmia University, Urmia, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Majid</FirstName>
        <LastName>Ebrahimi</LastName>
        <affiliation locale="en_US">Genomics Division, Systems Biology Institute, Chemical Injury Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran AND Department of Organ Anatomy, Yamaguchi University Graduate School of Medicine, Ube, Japan</affiliation>
      </Author>
      <Author>
        <FirstName>Samaneh</FirstName>
        <LastName>Yazdani</LastName>
        <affiliation locale="en_US">Genomics Division, Systems Biology Institute, Chemical Injury Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran AND Department of Pathology, Tohoku University GraduateSchool of Medicine, Sendai, Japan</affiliation>
      </Author>
      <Author>
        <FirstName>Mostafa</FirstName>
        <LastName>Ghanei</LastName>
        <affiliation locale="en_US">Genomics Division, Systems Biology Institute, Chemical Injury Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Mohammad Hassan</FirstName>
        <LastName>Karimfar</LastName>
        <affiliation locale="en_US">Department of Anatomy, Medical School, Ilam University of Medical Sciences, Ilam, Iran</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2015</Year>
        <Month>10</Month>
        <Day>16</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">The widespread use of sulfur mustard&#xA0; (SM) as a chemical warfare agent in the&#xA0; past century has proved its long-lasting toxic effects. Despite a lot of research over the past decades on Iranian veterans, there are still major gaps in the SM literature. Transforming growth&#xA0; factor&#xA0; (TGF-&#x3B2;),&#xA0; a&#xA0; cytokine&#xA0; that&#xA0; affects&#xA0; many&#xA0; different&#xA0; cell processes,&#xA0; has&#xA0; an important role in the lungs of patients with some of chronic airway diseases, especially with respect to airway remodeling in mustard lung.
Primary airway fibroblasts from epibronchial biopsies were cultured, and gene expression of TGF-&#x3B2;1, TGF-&#x3B2;2, TbR-I and TbR-II in fibroblasts of SM injured patients and controls were investigated. Expression of TGF-&#x3B2;s and receptors was measured by RT-PCR. Protein level of TGF-&#x3B2;1was surveyed by western blot.
Our&#xA0; findings revealed that expression levels of TGF-&#x3B2;1,&#xA0; TGF-&#x3B2;2,&#xA0; TbR-I and TbR-II were upregulated in the&#xA0; airway fibroblasts of&#xA0; SM exposed patients&#xA0; in comparison&#xA0; with control samples. TGF-&#x3B2;1 expression was shown to be markedly increased in primary lung fibroblasts of chemically injured patients.
Our&#xA0; novel data, suggested that&#xA0; over-expression of TGF-&#x3B2;&#xA0; molecule and receptors&#xA0; in primary airway fibroblasts of mustard gas injured patients may be involved in progression of airway remodeling of these patients.</abstract>
    <web_url>https://ijaai.tums.ac.ir/index.php/ijaai/article/view/520</web_url>
    <pdf_url>https://ijaai.tums.ac.ir/index.php/ijaai/article/download/520/500</pdf_url>
  </Article>
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Iranian Journal of Allergy, Asthma and Immunology</JournalTitle>
      <Issn>1735-1502</Issn>
      <Volume>12</Volume>
      <Issue>2</Issue>
      <PubDate PubStatus="epublish">
        <Year>2013</Year>
        <Month>06</Month>
        <Day>15</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Downregulation of Super Oxide Dismutase Level in Protein Might Be Due to Sulfur Mustard Induced Toxicity in Lung</title>
    <FirstPage>153</FirstPage>
    <LastPage>160</LastPage>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Leila</FirstName>
        <LastName>Mirbagheri</LastName>
        <affiliation locale="en_US">Genomics Division, Systems Biology Institute. Chemical Injuries Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran AND Biochemistry Department, Sciences and Technology Branch, Azad University, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Mehryar</FirstName>
        <LastName>Habibi Roudkenar</LastName>
        <affiliation locale="en_US">Research Center, Iranian Blood Transfusion Organization, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Abbas Ali</FirstName>
        <LastName>Imani Fooladi</LastName>
        <affiliation locale="en_US">Applied Microbiology Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Mostafa</FirstName>
        <LastName>Ghanei</LastName>
        <affiliation locale="en_US">Genomics Division, Systems Biology Institute. Chemical Injuries Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Mohammad Reza</FirstName>
        <LastName>Nourani</LastName>
        <affiliation locale="en_US">Genomics Division, Systems Biology Institute. Chemical Injuries Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2015</Year>
        <Month>10</Month>
        <Day>16</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Sulfur mustard (SM) has been identified as an important chemical weapon. During the Iran-Iraq war of 1980-88, the extensive usage of SM against Iranian civilians and military forces was proven. This agent has been shown to cause severe damage mainly in the skin, eyes, lungs,&#xA0; and&#xA0; respiratory&#xA0; tract&#xA0; in&#xA0; Iranian&#xA0; veterans.&#xA0; The&#xA0; most&#xA0; common&#xA0; disease&#xA0; is bronchiolitis obliterans (BO)). SM increases the endogenous production of reactive oxygen species (ROS). Superoxide dismutases (SODs) are known as protective antioxidants against the harmful effects of ROS.
Twenty exposed SM individuals (43.2&#xB1;6.4 years), and 10 normal controls (41.3&#xB1;2.5 years) were enrolled in this study. Evaluation of SODs was performed by semiquantitative RT-PCR and mmunohistochemistry.
Our&#xA0; results&#xA0; demonstrated&#xA0; that&#xA0; CuZnSOD&#xA0;&#xA0; and&#xA0; MnSOD&#xA0; mRNA&#xA0; were&#xA0; up-regulated 2.79&#xB1;1.09&#xA0; and&#xA0; 2.49&#xB1;1.11&#xA0; folds, respectively in SM-injured patients&#xA0; in comparison&#xA0; with control&#xA0; levels. In&#xA0; contrast,&#xA0; Immunohistochemistry&#xA0; results&#xA0; showed&#xA0; downregulation&#xA0; of CuZnSOD protein expression in SM injured patients.
Our results revealed that SODs may play an important role in cellular protection against oxidative stress due to mustard gas toxicity in airway wall of SM exposed patients.</abstract>
    <web_url>https://ijaai.tums.ac.ir/index.php/ijaai/article/view/519</web_url>
    <pdf_url>https://ijaai.tums.ac.ir/index.php/ijaai/article/download/519/503</pdf_url>
  </Article>
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Iranian Journal of Allergy, Asthma and Immunology</JournalTitle>
      <Issn>1735-1502</Issn>
      <Volume>12</Volume>
      <Issue>2</Issue>
      <PubDate PubStatus="epublish">
        <Year>2013</Year>
        <Month>06</Month>
        <Day>15</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Effect of Toll-Like Receptor 3 Agonists on the Functionality and Metastatic Properties of Breast Cancer Cell Model</title>
    <FirstPage>161</FirstPage>
    <LastPage>167</LastPage>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Nastaran</FirstName>
        <LastName>Alizadeh</LastName>
        <affiliation locale="en_US">Department of Immunology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Mohammad Mehdi</FirstName>
        <LastName>Amiri</LastName>
        <affiliation locale="en_US">Department of Pathobiology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Alireza</FirstName>
        <LastName>Salek Moghadam</LastName>
        <affiliation locale="en_US">Department of Immunology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Amir Hassan</FirstName>
        <LastName>Zarnani</LastName>
        <affiliation locale="en_US">Department of Immunology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Farshid</FirstName>
        <LastName>Saadat</LastName>
        <affiliation locale="en_US">Department of Immunology, School of Medicine, Guilan University of Medical Sciences, Rasht, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Farnaz</FirstName>
        <LastName>Safavifar</LastName>
        <affiliation locale="en_US">Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Research Institute, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Azar</FirstName>
        <LastName>Berahmeh</LastName>
        <affiliation locale="en_US">Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Research Institute, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Mohammad Reza</FirstName>
        <LastName>Khorramizadeh</LastName>
        <affiliation locale="en_US">Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Research Institute, Tehran University of Medical Sciences, Tehran, Iran AND Biosensor Research Center, Endocrinology and Metabolism Molecular-Cellular Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran AND Department of Medical Biotechnology, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2015</Year>
        <Month>10</Month>
        <Day>16</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">There exists compelling evidence that Toll-like receptor 3 (TLR3) agonists can directly affect human cancer cells. The aim of this study was to investigate anti-cancer effects of TLR3 agonist in human breast cell line.
We assessed potential effects of poly (A:U) on human breast cell line (MDA-MB-231)&#xA0; on a dose-response and time-course&#xA0; basis. Human breast cell line&#xA0; MDA-MB-231&#xA0; was treated with different concentrations of poly (A:U) and lipopolysaccharide&#xA0; (LPS). Then, the following assays were performed on the treated cells: dose-response&#xA0; and time-course cytotoxicity using colorimetric method; matrix metalloproteinase-2&#xA0; (MMP-2) activity using gelatin zymography method; apoptosis using annexin-v flowcytometry method; and relative expression of TLR3 and MMP-2 mRNA using reverse transcriptase&#xA0; polymerase chain reaction (RT-PCR) method. Following treatments, dose- response and time-course cytotoxicity using a colorimetric method, (MMP-2) activity (using gelatin zymography), apoptosis&#xA0; (using annexin-v flowcytometry method) assays and expression of TLR3 and MMP-2 genes (using PCR method) were performed.
Cytotoxicity and flowcytometry analysis of poly (A:U) showed that poly (A:U) do not have any cytotoxic and apoptotic effects in different concentrations used. MMP-2 activity analysis showed significant decrease in higher concentrations&#xA0; (50 and 100 &#xB5;g/ ml) between treated and untreated cells.&#xA0; Moreover, poly A:U treated cells demonstrated decreased expression of MMP-2 gene in higher concentrations.
Collectively, our data indicated that human breast cancer cell line (MDA-MB-231) was highly responsive to poly (A:U). The antimetastatic effect of direct poly (A:U) and TLR3 interactions in MDA-MB-231 cells could provide new approaches in malignant tumor therapeutic strategy.</abstract>
    <web_url>https://ijaai.tums.ac.ir/index.php/ijaai/article/view/518</web_url>
    <pdf_url>https://ijaai.tums.ac.ir/index.php/ijaai/article/download/518/514</pdf_url>
  </Article>
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Iranian Journal of Allergy, Asthma and Immunology</JournalTitle>
      <Issn>1735-1502</Issn>
      <Volume>12</Volume>
      <Issue>2</Issue>
      <PubDate PubStatus="epublish">
        <Year>2013</Year>
        <Month>06</Month>
        <Day>15</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Th1/Th2 Cytokines in Patients with Graves' Disease with or without Ophthalmopathy</title>
    <FirstPage>168</FirstPage>
    <LastPage>175</LastPage>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Fatemeh</FirstName>
        <LastName>Esfahanian</LastName>
        <affiliation locale="en_US">Department of Endocrinology, Imam Khomeini Hospital, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Effat</FirstName>
        <LastName>Naimi</LastName>
        <affiliation locale="en_US">Department of Endocrinology, Baqiyatallah University of Medical sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Farideh</FirstName>
        <LastName>Doroodgar</LastName>
        <affiliation locale="en_US">Eye Research Center, Imam Khomeini Hospital, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Zohre</FirstName>
        <LastName>Jadali</LastName>
        <affiliation locale="en_US">Department of Pathobiology, Immunology Division, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2015</Year>
        <Month>10</Month>
        <Day>16</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">About 25-50% of Graves' disease (GD) patients develop thyroid eye diseases, which is associated with inflammatory process and abnormalities in the levels of several cytokines in orbital tissues in GD.&#xA0; The aim of this study was to determine the Th1 and Th2 serum cytokines in patients with GD with or without ophthalmopathy.
Serum&#xA0; levels of&#xA0; cytokines&#xA0; and&#xA0; autoantibodies&#xA0; including Interferon-gamma&#xA0; (IFN-&#x3B3;),Interleukin-2 (IL-2), Interleukin-4 (IL-4), Interleukin-10 (IL-10), TSH receptor autoantibody (TRAb), thyroid&#xA0; peroxidase antibody (TPOAb)&#xA0; and&#xA0; thyroglobulin antibody(TgAb) were measured by enzyme linked immunosorbent assay(ELISA) in 34 patients with GD and in 33 normal controls. Patients were also divided in two subgroups: 18 cases with ophthalmopathy and 16 cases without ophthalmopathy. Cytokine and antibody responses were analyzed in both groups.
Compared with control subjects, patients with GD&#xA0; showed elevated levels of IL-2 and IL-10. IFN-&#x3B3;&#xA0; levels were lower in patients in comparison to the controls. No significant differences were found&#xA0; between patients and controls regarding the IL-4. There was no statistically significant&#xA0; difference&#xA0; in&#xA0; cytokine&#xA0; levels&#xA0; between&#xA0; those&#xA0;&#xA0; with&#xA0; or&#xA0;&#xA0; without ophthalmopathy.
Quantitative-cytokine&#xA0; analysis&#xA0; demonstrated&#xA0; that&#xA0; a&#xA0; combination&#xA0; of&#xA0; Th1&#xA0; and&#xA0; Th2 cytokines may contribute to the pathogenesis of GD. These results also indicate that IL-10, but not IL-4, is related to the moderate and severe forms of thyroid associated ophthalmophathy.</abstract>
    <web_url>https://ijaai.tums.ac.ir/index.php/ijaai/article/view/517</web_url>
    <pdf_url>https://ijaai.tums.ac.ir/index.php/ijaai/article/download/517/515</pdf_url>
  </Article>
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Iranian Journal of Allergy, Asthma and Immunology</JournalTitle>
      <Issn>1735-1502</Issn>
      <Volume>12</Volume>
      <Issue>2</Issue>
      <PubDate PubStatus="epublish">
        <Year>2013</Year>
        <Month>06</Month>
        <Day>15</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Psychiatric Aspects of Primary Immunodeficiency Diseases: The Parental Study</title>
    <FirstPage>176</FirstPage>
    <LastPage>181</LastPage>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Hassan</FirstName>
        <LastName>Abolhassani</LastName>
        <affiliation locale="en_US">Research Center for Immunodeficiencies, Pediatrics Center of Excellence, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Asghar</FirstName>
        <LastName>Aghamohammadi</LastName>
        <affiliation locale="en_US">Research Center for Immunodeficiencies, Pediatrics Center of Excellence, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Sarvenaz</FirstName>
        <LastName>Pourjabbar</LastName>
        <affiliation locale="en_US">Research Center for Immunodeficiencies, Pediatrics Center of Excellence, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Mohammad</FirstName>
        <LastName>Salehi Sadaghiani</LastName>
        <affiliation locale="en_US">Research Center for Immunodeficiencies, Pediatrics Center of Excellence, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Sina</FirstName>
        <LastName>Nikayin</LastName>
        <affiliation locale="en_US">Research Center for Immunodeficiencies, Pediatrics Center of Excellence, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Anahita</FirstName>
        <LastName>Rabiee</LastName>
        <affiliation locale="en_US">Research Center for Immunodeficiencies, Pediatrics Center of Excellence, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Amir</FirstName>
        <LastName>Imanzadeh</LastName>
        <affiliation locale="en_US">Research Center for Immunodeficiencies, Pediatrics Center of Excellence, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Javad</FirstName>
        <LastName>Mahmmoodi Gharaei</LastName>
        <affiliation locale="en_US">Department of Psychiatric, Rozbeh Hospital, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Mohammad</FirstName>
        <LastName>Arbabi</LastName>
        <affiliation locale="en_US">Department of Psychiatric, Rozbeh Hospital, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Nima</FirstName>
        <LastName>Rezaei</LastName>
        <affiliation locale="en_US">Research Center for Immunodeficiencies, Pediatrics Center of Excellence, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran AND Molecular Immunology Research Center; and Department of Immunology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2015</Year>
        <Month>10</Month>
        <Day>16</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Primary immunodeficiency diseases (PID) consist of a group of long-term illnesses which had permanent psychiatric effects on the patients and their parents. This study was designed to find out the most important origins and aspects of stressor in parents of PID patients.To assess the&#xA0; impact of&#xA0; psychiatric aspects in parents&#xA0; of PID&#xA0; patients, a valid and reliable questionnaire was compiled based on patients' complaints and consulting professionals in PID and psychology.
Fathers of 26 PID patients (17 male and 9 female) were enrolled in this study. According to the result of this study, anxiety for long duration of disease of child (mean score= 4.42), anxiety for incurable diseases of child (mean score=4.23) and anxiety for side effects and complication of treatments on child (mean score=4.08) were the most important stressors of parents.
The&#xA0; comparison&#xA0; between&#xA0; specific PID&#xA0; groups&#xA0; showed&#xA0; that&#xA0; there&#xA0; were&#xA0; significant differences between total score of groups (XLA= 92.8&#xB1;31.2, CVID=78.7&#xB1;19.5 and other types of PID=&#xA0; 90.7&#xB1;22.5, p-value =0.37).
Survey for finding fundamental stressors and continuation of psychological counseling are necessary to achieve successful management of PID patients and their parents.</abstract>
    <web_url>https://ijaai.tums.ac.ir/index.php/ijaai/article/view/516</web_url>
    <pdf_url>https://ijaai.tums.ac.ir/index.php/ijaai/article/download/516/517</pdf_url>
  </Article>
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Iranian Journal of Allergy, Asthma and Immunology</JournalTitle>
      <Issn>1735-1502</Issn>
      <Volume>12</Volume>
      <Issue>2</Issue>
      <PubDate PubStatus="epublish">
        <Year>2013</Year>
        <Month>06</Month>
        <Day>15</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">The Relation of Multiple Sclerosis with Allergy and Atopy: A Case Control Study</title>
    <FirstPage>182</FirstPage>
    <LastPage>189</LastPage>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Parisa</FirstName>
        <LastName>Karimi</LastName>
        <affiliation locale="en_US">Immunology, Asthma and Allergy Research Institute, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Seyedeh Zalfa</FirstName>
        <LastName>Modarresi</LastName>
        <affiliation locale="en_US">Immunology, Asthma and Allergy Research Institute, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Mohammad Ali</FirstName>
        <LastName>Sahraian</LastName>
        <affiliation locale="en_US">Department of Neurology, Sina Hospital, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Raheleh</FirstName>
        <LastName>Shokouhi Shoormasti</LastName>
        <affiliation locale="en_US">Immunology, Asthma and Allergy Research Institute, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Maryam</FirstName>
        <LastName>Mahlooji</LastName>
        <affiliation locale="en_US">Immunology, Asthma and Allergy Research Institute, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Anoushirvan</FirstName>
        <LastName>Kazemnejad</LastName>
        <affiliation locale="en_US">Department of Biostatistics, Tarbiat Modares University, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Zahra</FirstName>
        <LastName>Pourpak</LastName>
        <affiliation locale="en_US">Immunology, Asthma and Allergy Research Institute, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2015</Year>
        <Month>10</Month>
        <Day>16</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Multiple Sclerosis (MS) and Allergy are believed to up regulate T helper cell type 1 (Th1) and T helper cell type 2 (Th2) responses, respectively. It has been shown that disequilibrium in the&#xA0; ratio&#xA0; of&#xA0; Th1/Th2&#xA0; activities may increase frequency of&#xA0; one&#xA0; disease and&#xA0; decrease the frequency of the other. The aim of this study was to investigate the relation of MS with allergy and atopy in new diagnosed MS patients.
This case-control study was conducted on 40 new diagnosed MS patients and the same number&#xA0; of&#xA0; normal controls. All of&#xA0; the&#xA0; patients were diagnosed (according to&#xA0; McDonald criteria) at most 2 years prior to the study. Demographic data and clinical characteristics of both groups were recorded in a questionnaire. The total IgE and allergen specific IgE in the serum were measured in all the cases.
Forty MS patients (female/male: 4.71) with mean age of 30.55&#xB1;9.5 years and 40 healthy controls entered in this study. History of allergy was observed in 20(50%) of MS patients (including 15 (37.5%) rhinitis, 6 (15%) conjunctivitis, 3 (7.5%) urticaria and eczema, 1 (2.5%) asthma), and 20 (50%) of the controls (including 8 (20%) rhinitis, 4 (10%) conjunctivitis, 7 (17.5%) urticaria and eczema, 1 (2.5%) asthma). The differences between the two groups were not&#xA0; statistically significant. Neither the serum total IgE, nor the frequency of specific IgE against Weed mix, Grass Mix, Tree mix1, Tree mix 2, Dermatophagoides Farinae, Dermatophagoides pteronyssinus and Epidermal and animal proteins mix differed statistically between the&#xA0; two&#xA0; groups. There&#xA0; was also no&#xA0; significant relationship between MS clinical manifestations and allergy prevalence and also between MS and atopy.
&#xA0;The results of this study as some other similar studies showed the same prevalence of allergy in MS patients and controls and also demonstrated no relation between MS and atopy.</abstract>
    <web_url>https://ijaai.tums.ac.ir/index.php/ijaai/article/view/515</web_url>
    <pdf_url>https://ijaai.tums.ac.ir/index.php/ijaai/article/download/515/518</pdf_url>
  </Article>
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Iranian Journal of Allergy, Asthma and Immunology</JournalTitle>
      <Issn>1735-1502</Issn>
      <Volume>12</Volume>
      <Issue>2</Issue>
      <PubDate PubStatus="epublish">
        <Year>2013</Year>
        <Month>06</Month>
        <Day>15</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Factors Affecting the Severity of Cow&#x2019;s Milk Anaphylaxis</title>
    <FirstPage>190</FirstPage>
    <LastPage>191</LastPage>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Pegah</FirstName>
        <LastName>Teymourpour</LastName>
        <affiliation locale="en_US">Immunology, Asthma and Allergy Research Institute, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Raheleh</FirstName>
        <LastName>Shokouhi</LastName>
        <affiliation locale="en_US">Immunology, Asthma and Allergy Research Institute, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Mohammad Reza</FirstName>
        <LastName>Fazlollahi</LastName>
        <affiliation locale="en_US">Immunology, Asthma and Allergy Research Institute, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Masoud</FirstName>
        <LastName>Movahedi</LastName>
        <affiliation locale="en_US">Immunology, Asthma and Allergy Research Institute, Tehran University of Medical Sciences, Tehran, Iran AND Department of Immunology and Allergy, Children&#x2019;s Medical Center, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Mahboobeh</FirstName>
        <LastName>Mansouri</LastName>
        <affiliation locale="en_US">Pediatric Infections Research Center (PIRC), Mofid Children&#x2019;s Hospital, Shaheed Beheshti University of Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Bahram</FirstName>
        <LastName>Mirsaeedghazi</LastName>
        <affiliation locale="en_US">Department of Pediatric, Bahrami Hospital, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Anoshirvan</FirstName>
        <LastName>Kazemnejad</LastName>
        <affiliation locale="en_US">Department of Biostatistics, Tarbiat Modares University, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Seyedeh Kimia</FirstName>
        <LastName>Yavari</LastName>
        <affiliation locale="en_US">Immunology, Asthma and Allergy Research Institute, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Zahra</FirstName>
        <LastName>Pourpak</LastName>
        <affiliation locale="en_US">Immunology, Asthma and Allergy Research Institute, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Mostafa</FirstName>
        <LastName>Moin</LastName>
        <affiliation locale="en_US">Immunology, Asthma and Allergy Research Institute, Tehran University of Medical Sciences, Tehran, Iran AND Department of Immunology and Allergy, Children&#x2019;s Medical Center, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2015</Year>
        <Month>10</Month>
        <Day>16</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">No Abstract</abstract>
    <web_url>https://ijaai.tums.ac.ir/index.php/ijaai/article/view/514</web_url>
    <pdf_url>https://ijaai.tums.ac.ir/index.php/ijaai/article/download/514/519</pdf_url>
  </Article>
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Iranian Journal of Allergy, Asthma and Immunology</JournalTitle>
      <Issn>1735-1502</Issn>
      <Volume>12</Volume>
      <Issue>2</Issue>
      <PubDate PubStatus="epublish">
        <Year>2013</Year>
        <Month>06</Month>
        <Day>15</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Immunogenicity Assessment of Brucella mellitensis HSP and TF Proteins by Immunized Rabbit Serum</title>
    <FirstPage>192</FirstPage>
    <LastPage>194</LastPage>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Amir</FirstName>
        <LastName>Ghasemi</LastName>
        <affiliation locale="en_US">Department of Pathobiology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Mohammad Hossein</FirstName>
        <LastName>Salari</LastName>
        <affiliation locale="en_US">Department of Pathobiology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Amir Hassan</FirstName>
        <LastName>Zarnani</LastName>
        <affiliation locale="en_US">Nanobiotechnology Research Center, Avicenna Research Institute, ACECR, Tehran, Iran AND Immunology Research Center, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Mohammad Reza</FirstName>
        <LastName>Pourmand</LastName>
        <affiliation locale="en_US">Department of Pathobiology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Hojat</FirstName>
        <LastName>Ahmadi</LastName>
        <affiliation locale="en_US">Department of Bacterial Vaccines and Antigen Production, Pasteur Institute of Iran, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Mohamad Hassan</FirstName>
        <LastName>Shirazi</LastName>
        <affiliation locale="en_US">Department of Pathobiology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Mahmood</FirstName>
        <LastName>Jeddi-Tehrani</LastName>
        <affiliation locale="en_US">Monoclonal Antibody Research Center, Avicenna Research Institute, ACECR, Tehran, Iran</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2015</Year>
        <Month>10</Month>
        <Day>16</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">No Abctract</abstract>
    <web_url>https://ijaai.tums.ac.ir/index.php/ijaai/article/view/513</web_url>
    <pdf_url>https://ijaai.tums.ac.ir/index.php/ijaai/article/download/513/520</pdf_url>
  </Article>
</Articles>
